Document:

Third Amendment Agreement, dated June 30, 2009

 Exhibit 10.1 
 THIRD AMENDMENT AGREEMENT 
 This THIRD AMENDMENT AGREEMENT (this “Amendment”)
is made as of the 30th day of June, 2009, among: 
 (a) SHILOH INDUSTRIES, INC., a Delaware corporation (“Borrower”); 
 (b) the Lenders, as defined in the Credit Agreement, as hereinafter defined; 
 (c) NATIONAL CITY BANK, as the co-lead arranger, sole book runner and administrative agent for the Lenders under the Credit Agreement
(“Agent”); and 
 (d) THE PRIVATEBANK AND TRUST COMPANY, as the co-lead arranger and syndication agent. 
 WHEREAS, Borrower, Agent and the Lenders are parties to that certain Credit and Security Agreement, dated as of August 1, 2008, that provides, among
other things, for loans and letters of credit aggregating One Hundred Twenty Million Dollars ($120,000,000), all upon certain terms and conditions (as amended and as the same may from time to time be further amended, restated or otherwise modified,
the “Credit Agreement”); 
 WHEREAS, Borrower’s business has experienced significant disruption as a result of the
unprecedented events occurring in the automotive industry, including the bankruptcy filings of General Motors Corporation and Chrysler Group LLC (collectively, the “Auto Industry Conditions”), as well as the general downturn in the global
economy; 
 WHEREAS, the unusual and uncertain circumstances within the auto industry, and the lack of visibility with respect to demand for
autos and other factors that impact Borrower’s business make it difficult to forecast beyond a relatively short period of time with a reasonably high level of confidence; therefore, the covenants being addressed in this Amendment will continue
to focus on short-term performance; 
 WHEREAS, Borrower anticipates that more accurate financial information regarding forecasts will be
available to Borrower prior to October 31, 2009; 
 WHEREAS, Agent and the Lenders intend to have appraisals and field examinations
conducted with respect to the assets of Borrower that will assist in the evaluation of the Companies; 
 WHEREAS, Borrower, Agent and the
Lenders desire to amend the Credit Agreement to modify certain provisions thereof and add certain provisions thereto; 
 WHEREAS, each
capitalized term used herein and defined in the Credit Agreement, but not otherwise defined herein, shall have the meaning given such term in the Credit Agreement; and 

 WHEREAS, unless otherwise specifically provided herein, the provisions of the Credit Agreement revised
herein are amended effective as of the date of this Amendment; 
 NOW, THEREFORE, in consideration of the premises and of the mutual
covenants herein and for other valuable consideration, Borrower, Agent and the Lenders agree as follows: 
 1. Amendment to
Definitions. Section 1.1 of the Credit Agreement is hereby amended to delete the definitions of “Applicable Margin”, “Base Rate”, “Closing Commitment Amount”, “Commitment Period”, “Consolidated
EBITDA”, “Eurodollar Rate”, “Fixed Charge Coverage Ratio”, “Interest Period”, “Leverage Ratio”, “Related Writing”, and “Revolving Credit Commitment” therefrom and to insert in place
thereof, respectively, the following: 
 “Applicable Margin” means (a) five hundred (500.00) basis points
for Eurodollar Loans, and (b) four hundred (400.00) basis points for Base Rate Loans. 
 “Base Rate” means
a rate per annum equal to the highest of (a) the Prime Rate, (b) one-half of one percent (.50%) in excess of the Federal Funds Effective Rate, or (c) the Daily LIBOR Rate plus one percent (1.00%). 
 “Closing Commitment Amount” means Ninety-Five Million Dollars ($95,000,000). 
 “Commitment Period” means the period from the Closing Date to July 31, 2012, or such earlier date on which the Commitment
shall have been terminated pursuant to Article IX hereof. 
 “Consolidated EBITDA” means, for any period, as
determined on a Consolidated basis and in accordance with GAAP, (a) Consolidated Net Earnings for such period plus, without duplication, the aggregate amounts deducted in determining such Consolidated Net Earnings in respect of
(i) Consolidated Interest Expense, (ii) Consolidated Income Tax Expense, (iii) Consolidated Depreciation and Amortization Charges, (iv) extraordinary or unusual non-cash losses not incurred in the ordinary course of business (but
that were counted in the net income calculation for such period), in an aggregate amount not to exceed Two Hundred Thousand Dollars ($200,000), (v) non-cash expenses related to the issuance of employee stock incentive options, (vi) any
Related Expenses incurred during such period, (vii) non-cash charges resulting from changes in estimates or assumptions related to employee retirement and health benefit plans, and (viii) costs and expenses (including appraisal costs and
fees) of Borrower incurred in connection with the Third Amendment Agreement during such period; minus (b) to the extent included in Consolidated Net Earnings for such period, non-recurring or non-cash gains not incurred in the ordinary course
of business; provided that, at any time an Acquisition is made pursuant to Section 5.13 hereof, Consolidated EBITDA shall be recalculated to include the EBITDA of the acquired company (with appropriate pro-forma adjustments, reasonably
acceptable to Agent and the Required Lenders, due to discontinued 

  

 2 

 
operations, and expenses and synergies directly related thereto) as if such Acquisition had been completed on the first day of the relevant measuring period.

 “Eurodollar Rate” means, with respect to a Eurodollar Loan, for any Interest Period, a rate
per annum equal to the greater of (a) the quotient obtained (rounded upwards, if necessary, to the nearest  1/16th of 1%) by dividing (i) the rate of interest, determined by Agent in accordance with its
usual procedures (which determination shall be conclusive absent manifest error) as of approximately 11:00 A.M. (London time) two Business Days prior to the beginning of such Interest Period pertaining to such Eurodollar Loan, as listed on British
Bankers Association Interest Rate LIBOR 01 or 02 as provided by Reuters or Bloomberg (or, if for any reason such rate is unavailable from Reuters or Bloomberg, from any other similar company or service that provides rate quotations comparable to
those currently provided by Reuters or Bloomberg) as the rate in the London interbank market for Dollar deposits in immediately available funds with a maturity comparable to such Interest Period, provided that, in the event that such rate quotation
is not available for any reason, then the Eurodollar Rate shall be the average (rounded upward to the nearest  1/16th of 1%) of
the per annum rates at which deposits in immediately available funds in Dollars for the relevant Interest Period and in the amount of the Eurodollar Loan to be disbursed or to remain outstanding during such Interest Period, as the case may be, are
offered to Agent (or an affiliate of Agent, in Agent’s discretion) by prime banks in any Eurodollar market reasonably selected by Agent, determined as of 11:00 A.M. (London time) (or as soon thereafter as practicable), two Business Days prior
to the beginning of the relevant Interest Period pertaining to such Eurodollar Loan; by (ii) 1.00 minus the Reserve Percentage; and (b) two percent (2.00%). 
 “Fixed Charge Coverage Ratio” means, as determined for the most recently completed twelve calendar months, on a Consolidated
basis and in accordance with GAAP, the ratio of (a) (i) Consolidated EBITDA, minus (ii) the sum of (A) Consolidated Capital Expenditures, and (B) Capital Distributions (other than the 2008 Special Dividend); to
(b) Consolidated Fixed Charges. 
 “Interest Period” means, with respect to a Eurodollar Loan, the period
commencing on the date such Eurodollar Loan is made and ending on the last day of such period, as selected by Borrower pursuant to the provisions hereof, and, thereafter (unless such Eurodollar Loan is converted to a Base Rate Loan), each subsequent
period commencing on the last day of the immediately preceding Interest Period and ending on the last day of such period, as selected by Borrower pursuant to the provisions hereof. The duration of each Interest Period for a Eurodollar Loan shall be
one month. 
 “Leverage Ratio” means, as determined on a Consolidated basis and in accordance with GAAP, the ratio
of (a) Consolidated Funded Indebtedness (for the most recently completed calendar month), to (b) Consolidated EBITDA (for the most recently completed twelve calendar months). 
 “Related Writing” means each Loan Document, each Borrowing Formula Certificate and any other assignment, mortgage, security
agreement, guaranty agreement, 

  

 3 

 
subordination agreement, financial statement, audit report or other writing furnished by any Credit Party, or any of its officers, to Agent or the Lenders
pursuant to or otherwise in connection with this Agreement. 
 “Revolving Credit Commitment” means the obligation
hereunder, during the Commitment Period, of (a) the Lenders to make Revolving Loans, (b) the Fronting Lenders to issue and the Lenders to participate in, Letters of Credit pursuant to the Letter of Credit Commitment, and (c) the Swing
Line Lender to make, and the Lenders to participate in, Swing Loans pursuant to the Swing Line Commitment; up to an aggregate principal amount outstanding at any time equal to the lesser of (a) the Borrowing Formula, or (b) the Total
Commitment Amount. 
 2. Additions to Definitions. Section 1.1 of the Credit Agreement is hereby amended to add the following new
definitions thereto: 
 “Borrowing Formula” means an amount equal to the sum of the following: 
 (a) the aggregate of the net book value of all of the accounts receivable of Borrower, as determined in accordance with GAAP; plus

 (b) the aggregate of the net book value of all of the Inventory of Borrower, as determined in accordance with GAAP; plus

 (c)(i) for the period from the Third Amendment Effective Date through August 31, 2009, Forty-Five Million Dollars
($45,000,000), and (ii) for the period from September 1, 2009 and thereafter, Forty Million Dollars ($40,000,000); minus 
 (d) the aggregate of the net book value of all amounts due and owing on accounts payable by Borrower, as determined in accordance with GAAP. 
 “Borrowing Formula Certificate” means a Borrowing Formula Certificate, in the form of the attached Exhibit G. 
 “Daily LIBOR Rate” means, for any day, the rate per annum determined by Agent by dividing (a) the Published Rate by
(b) a number equal to 1.00 minus the Reserve Percentage on such day. 
 “Published Rate” shall mean the rate of
interest published each Business Day in The Wall Street Journal “Money Rates” listing under the caption “London Interbank Offered Rates” for a one month period (or, if no such rate is published therein for any reason, then the
Published Rate shall be the rate at which U.S. dollar deposits are offered by leading banks in the London interbank deposit market for a one month period as published in another publication selected by Agent. 
  

 4 

 “Third Amendment Agreement” means that certain Third Amendment Agreement, dated
as of the Third Amendment Effective Date, among Borrower, Agent and the Lenders. 
 “Third Amendment Effective Date”
means June 30, 2009. 
 3. Amendment to Computation of Interest and Fees Provisions. Article II of the Credit Agreement is hereby
amended to delete section 2.10 therefrom and to insert in place thereof the following: 
 Section 2.10. Computation of
Interest and Fees. Interest on Loans, Letter of Credit fees, Related Expenses, and commitment and other fees and charges hereunder shall be computed on the basis of a year having three hundred sixty (360) days and calculated for the actual
number of days elapsed. 
 4. Amendment to Mandatory Payments Provisions. Section 2.11(c) of the Credit Agreement is hereby
amended to add the following new subpart (v) thereto: 
 (v) Aggregate Cash Balances. If, at any time, the
Companies maintain aggregate cash balances in excess of Five Million Dollars ($5,000,000) for any five consecutive calendar days, Borrower shall make a Mandatory Prepayment, on the last day of such five day period, in an amount equal to the
aggregate amount of cash in excess of Five Million Dollars ($5,000,000). Notwithstanding anything in this Section 2.11 to the contrary, any Mandatory Prepayment made pursuant to this subpart (v) shall not result in a permanent reduction of
the Revolving Credit Commitment. 
 5. Amendment to Financial Statements and Information Provisions. Section 5.3 of the Credit
Agreement is hereby amended to delete subsection (c) therefrom and to insert in place thereof the following: 
 (c)
Compliance Certificate. Borrower shall deliver to Agent and the Lenders, concurrently with the delivery of the financial statements set forth in subsections (a), (b) and (l) of this Section 5.3, a Compliance Certificate.

 6. Addition to Financial Statements and Information Provisions. Section 5.3 of the Credit Agreement is hereby amended to add
the following new subsections (j), (k) and (l) thereto: 
 (j) Borrowing Formula. Borrower shall deliver to
Agent and the Lenders, as frequently as Agent may request, but no less frequently than by 5:00 P.M. (Eastern time) on each Wednesday of each calendar week (or the next Business Day if such Wednesday is not a Business Day), (i) a Borrowing
Formula Certificate (for the period ending on the Business Day prior to the date such Borrowing Formula Certificate is submitted) prepared by a Financial Officer, and (ii) an Accounts aging report and a summary Inventory report, each in form
and substance satisfactory to Agent and signed by a Financial Officer. 
  

 5 

 (k) Cash Flow and Sales Forecasts and Reports. Borrower shall deliver to Agent and
the Lenders, on the Third Amendment Effective Date and by no later 5:00 P.M. (Eastern time) on each Wednesday of each calendar week (or the next Business Day if such Wednesday is not a Business Day), a rolling thirteen (13) week cash flow
forecast and sales forecast, each to be in form and substance acceptable to Agent and the Lenders. 
 (l) Monthly
Financials. Borrower shall deliver to Agent and the Lenders, on the Third Amendment Effective Date and within twenty (20) days after the end of each calendar month, a monthly financial reporting package, acceptable to Agent and the Required
Lenders, including, but not limited to, monthly financial statements, a reconciliation of the prior month actual results to the budget, and a variance analysis on cash flow and sales forecasts, all prepared on a Consolidated basis, in accordance
with GAAP and in form and detail satisfactory to Agent. 
 7. Amendment to Financial Covenants. Article V of the Credit Agreement is
hereby amended to delete Section 5.7 therefrom and to insert in place thereof the following: 
 Section 5.7.
Financial Covenants. 
 (a) Leverage Ratio. Borrower shall not suffer or permit at any time the Leverage Ratio
to exceed (i) 3.00 to 1.00 on the Closing Date through January 30, 2010, (ii) 2.75 to 1.00 on January 31, 2010 through January 30, 2011, and (iii) 2.50 to 1.00 on January 31, 2011 and thereafter; provided that
(A) if Borrower shall not be in compliance with this Section 5.7(a) for any period prior to November 30, 2009, such non-compliance shall not result in an Event of Default until November 30, 2009, and (B) if Borrower shall be
in compliance with this Section 5.7(a) for the period ending October 31, 2009, and shall have provided evidence to Agent and the Lenders of such compliance prior to November 30, 2009, then non-compliance with this Section 5.7(a)
for periods prior to October 31, 2009 shall be deemed to be waived. 
 (b) Fixed Charge Coverage Ratio. Borrower
shall not suffer or permit at any time the Fixed Charge Coverage Ratio to be less than 2.50 to 1.00; provided that (A) if Borrower shall not be in compliance with this Section 5.7(b) for any period prior to November 30, 2009, such
non-compliance shall not result in an Event of Default until November 30, 2009, and (B) if Borrower shall be in compliance with this Section 5.7(b) for the period ending October 31, 2009, and shall have provided evidence to Agent
and the Lenders of such compliance prior to November 30, 2009, then non-compliance with this Section 5.7(b) for periods prior to October 31, 2009 shall be deemed to be waived. 
 (c) Minimum Consolidated EBITDA. On and after the Third Amendment Effective Date, Borrower shall not suffer or permit at any time
Consolidated EBITDA, as determined for the most recently completed three consecutive calendar months, to be less than: 
  

 6 

 (i) negative One Million Three Hundred Eighty-Nine Thousand Four Hundred Eighty-Three
Dollars ($-1,389,483), on June 30, 2009; 
 (ii) negative Two Million Five Hundred Forty-Six Thousand Three Hundred
Ninety-Five Dollars ($-2,546,395), on July 31, 2009; 
 (iii) negative Five Hundred Ninety-Three Thousand Six Hundred Ten
Dollars ($-593,610), on August 31, 2009; 
 (iv) One Million Seven Hundred Sixty-Three Thousand Five Hundred Ninety-Two
Dollars ($1,763,592), on September 30, 2009; 
 (v) Two Million Nine Hundred Sixty-Nine Thousand Seven Hundred
Fifty-Three Dollars ($2,969,753), on October 31, 2009; 
 (vi) Three Million Six Hundred Sixty-One Thousand Two Hundred
Ninety Dollars ($3,661,290), on November 30, 2009; 
 (vii) Three Million Four Hundred Seventy-Five Thousand Three
Hundred Seventy-Nine Dollars ($3,475,379), on December 31, 2009; and 
 (viii) Two Million Eight Hundred Forty-Five
Thousand Nine Hundred Seventeen Dollars ($2,845,917), on January 31, 2010 and thereafter. 
 8. Amendment to Acquisitions
Provision. Section 5.13 of the Credit Agreement is hereby amended to add the following new proviso at the end thereof: 
 provided
that, on and after the Third Amendment Effective Date, no Company shall effect an Acquisition without the prior written consent of Agent and the Required Lenders. 
 9. Amendment to Covenants. Article V of the Credit Agreement is hereby amended to add the following new Section 5.30 and Section 5.31 thereto: 
 Section 5.30. Banking Relationship. Until payment in full of the Obligations, Borrower shall maintain its banking and
depository relationship (including, but not limited to, all Deposit Accounts and investment accounts) with one or more Lenders and all such accounts shall be subject to Control Agreements (or similar agreements); provided that Borrower may maintain
up to three Deposit Accounts at Bank of America, N.A. for a period not to exceed thirty (30) days after the Third Amendment Effective Date, so long as the balance in such accounts does not, in the aggregate, exceed Fifty Thousand Dollars
($50,000) at any time. 
 Section 5.31. Appraisals. Borrower hereby agrees that Agent (or a representative of
Agent), for the benefit of the Lenders, may (a) hire an appraisal firm to (i) conduct an appraisal of all of the Equipment of the Companies, which shall be in form and substance 

  

 7 

 
satisfactory to Agent, and (ii) conduct an appraisal of the Real Property of the Companies, which shall be in form and substance satisfactory to Agent,
and (b) conduct a field exam with respect to the current assets of the Companies, to be in form and substance satisfactory to Agent. Borrower hereby agrees to, promptly upon demand therefor, pay all costs and expenses incurred in connection
with such appraisals and field exams. Borrower agrees to cause the Companies to fully cooperate with such appraisals and field exams. 
 10.
Amendment to Schedules. The Credit Agreement is hereby amended to delete Schedule 1 (Commitment of Lenders) therefrom and to insert in place thereof a new Schedule 1 in the form of Schedule 1 hereto. 
 11. Addition to Exhibits. The Credit Agreement is hereby amended to add a new Exhibit G (Borrowing Formula Certificate) thereto in the form
of Exhibit G hereto. 
 12. Closing Deliveries. Concurrently with the execution of this Amendment, Borrower shall: 

(a) cause each Guarantor of Payment to execute the attached Guarantor Acknowledgment and Agreement; 
 (b) deliver to Agent and the Lenders the financial reports required to be delivered pursuant to Section 5.3 (k) and (l) of
the Credit Agreement; 
 (c) pay an amendment fee to Agent, for the pro rata benefit of the Lenders that shall have executed
and delivered this Amendment to Agent on or before 1:00 P.M. (Eastern time) on June 30, 2009 (each an “Approving Lender”), in an amount equal to twenty-five (25.00) basis points multiplied by the aggregate amount of the
Commitments (effective as of the Third Amendment Effective Date) of the Approving Lenders; and 
 (d) pay all legal fees and
expenses of Agent in connection with this Amendment. 
 13. Post-Closing Deliveries. No later than July 7, 2009, unless otherwise
agreed to by Agent in writing, Borrower shall have delivered to Agent a Processor’s Waiver, in form and substance satisfactory to Agent, for each location where a Company maintains any Inventory with a processor, together with (a) filed
appropriate U.C.C. Financing Statements to protect such Company’s interest therein, in form and substance satisfactory to Agent; and (b) evidence that proper notice has been given to all secured parties of such third party that have filed
U.C.C. Financing Statements (prior to the time of the filing of the U.C.C. Financing Statement of such Company) claiming a security interest in such third party’s inventory. 
 14. Representations and Warranties. Borrower hereby represents and warrants to Agent and the Lenders that (a) Borrower has the legal power
and authority to execute and deliver this Amendment; (b) the officers executing this Amendment have been duly authorized to execute and deliver the same and bind Borrower with respect to the provisions hereof; (c) the 

  

 8 

 
execution and delivery hereof by Borrower and the performance and observance by Borrower of the provisions hereof do not violate or conflict with the
Organizational Documents of Borrower or any law applicable to Borrower or result in a breach of any provision of or constitute a default under any other agreement, instrument or document binding upon or enforceable against Borrower; (d) no
Default or Event of Default will exist or occur immediately after the execution and delivery of this Amendment or by the performance or observance of any provision hereof; (e) each of the representations and warranties contained in the Loan
Documents is true and correct in all material respects as of the Third Amendment Effective Date as if made on the Third Amendment Effective Date, except to the extent that any such representation or warranty expressly states that it relates to an
earlier date (in which case such representation or warranty is true and correct in all material respects as of such earlier date); (f) Borrower is not aware of any claim or offset against, or defense or counterclaim to, Borrower’s
obligations or liabilities under the Credit Agreement or any Related Writing; and (g) this Amendment constitutes a valid and binding obligation of Borrower in every respect, enforceable in accordance with its terms. 
 15. Waiver and Release. Borrower, by signing below, hereby waives and releases Agent and each of the Lenders, and their respective directors,
officers, employees, attorneys, affiliates and subsidiaries, from any and all claims, offsets, defenses and counterclaims of which Borrower is aware, such waiver and release being with full knowledge and understanding of the circumstances and effect
thereof and after having consulted legal counsel with respect thereto. 
 16. References to Credit Agreement and Ratification. Each
reference that is made in the Credit Agreement or any other Related Writing shall hereafter be construed as a reference to the Credit Agreement as amended hereby. Except as herein otherwise specifically provided, all terms and provisions of the
Credit Agreement are confirmed and ratified and shall remain in full force and effect and be unaffected hereby. This Amendment is a Related Writing. 
 17. Counterparts. This Amendment may be executed in any number of counterparts, by different parties hereto in separate counterparts and by facsimile signature, each of which when so executed and delivered
shall be deemed to be an original and all of which taken together shall constitute but one and the same agreement. 
 18. Headings.
The headings, captions and arrangements used in this Amendment are for convenience only and shall not affect the interpretation of this Amendment. 
 19. Severability. Any term or provision of this Amendment held by a court of competent jurisdiction to be invalid or unenforceable shall not impair or invalidate the remainder of this Amendment and the effect thereof shall be
confined to the term or provision so held to be invalid or unenforceable. 
 20. Governing Law. The rights and obligations of all
parties hereto shall be governed by the laws of the State of Ohio, without regard to principles of conflicts of laws. 
 [Remainder of page
intentionally left blank.] 
  

 9 

 JURY TRIAL WAIVER. BORROWER, AGENT AND THE LENDERS, TO THE EXTENT PERMITTED BY LAW, EACH HEREBY
WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE, AMONG BORROWER, AGENT AND THE LENDERS, OR ANY THEREOF, ARISING OUT OF, IN CONNECTION WITH, RELATED TO, OR INCIDENTAL TO THE
RELATIONSHIP ESTABLISHED AMONG THEM IN CONNECTION WITH THIS AMENDMENT OR ANY NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED THERETO. THIS WAIVER SHALL NOT IN ANY WAY AFFECT,
WAIVE, LIMIT, AMEND OR MODIFY AGENT’S OR ANY LENDER’S ABILITY TO PURSUE REMEDIES PURSUANT TO ANY CONFESSION OF JUDGMENT OR COGNOVIT PROVISION CONTAINED IN ANY NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT AMONG BORROWER, AGENT AND THE
LENDERS. 
 IN WITNESS WHEREOF, the parties have executed and delivered this Amendment in Cleveland, Ohio as of the date first set forth
above. 
  

			
	SHILOH INDUSTRIES, INC.
		
	By:	 	 /s/ Thomas M. Dugan

		 	Thomas M. Dugan
		 	Treasurer
	
	 NATIONAL CITY BANK,
as Agent and as a Lender

		
	By:	 	 /s/ Robert S. Coleman

		 	Robert S. Coleman
		 	Senior Vice President
	
	 THE PRIVATEBANK AND TRUST COMPANY,
as Syndication Agent and as a Lender

		
	By:	 	 /s/ Robert M. Walker

		 	Robert M. Walker
		 	Managing Director

  

 Signature Page 1 of 2 to 
 Third Amendment Agreement 

			
	FIRSTMERIT BANK, N.A.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	KEYBANK NATIONAL ASSOCIATION
		
	By:	 	  

	Name:	 	  

	Title:	 	  

	
	RBS CITIZENS, NATIONAL ASSOCIATION
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

 Signature Page 2 of 2 to 
 Third Amendment Agreement 

 GUARANTOR ACKNOWLEDGMENT AND AGREEMENT 
 The undersigned consent and agree to and acknowledge the terms of the foregoing Third Amendment Agreement dated as of June 30, 2009. The undersigned
further agree that the obligations of the undersigned pursuant to the Guaranty of Payment executed by the undersigned are hereby ratified and shall remain in full force and effect and be unaffected hereby. 
 The undersigned hereby waive and release Agent and the Lenders and their respective directors, officers, employees, attorneys, affiliates and
subsidiaries from any and all claims, offsets, defenses and counterclaims of any kind or nature, absolute and contingent, of which the undersigned are aware or should be aware, such waiver and release being with full knowledge and understanding of
the circumstances and effect thereof and after having consulted legal counsel with respect thereto. 
 JURY TRIAL WAIVER. THE
UNDERSIGNED, TO THE EXTENT PERMITTED BY LAW, HEREBY WAIVE ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE, AMONG BORROWERS, AGENT, THE LENDERS AND THE UNDERSIGNED, OR ANY THEREOF,
ARISING OUT OF, IN CONNECTION WITH, RELATED TO, OR INCIDENTAL TO THE RELATIONSHIP ESTABLISHED AMONG THEM IN CONNECTION WITH THIS AMENDMENT OR ANY NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR THE
TRANSACTIONS RELATED THERETO. THIS WAIVER SHALL NOT IN ANY WAY AFFECT, WAIVE, LIMIT, AMEND OR MODIFY THE ABILITY OF AGENT AND LENDERS TO PURSUE REMEDIES PURSUANT TO ANY CONFESSION OF JUDGMENT OR COGNOVIT PROVISION CONTAINED IN ANY NOTE OR OTHER
INSTRUMENT, DOCUMENT OR AGREEMENT BETWEEN BORROWER, AGENT AND LENDERS. 
  

									
	SHILOH CORPORATION	 		 	GREENFIELD DIE & MANUFACTURING CORP.
					
	By:	 	 /s/ Thomas J. Stecz
	 		 	By:	 	 /s/ Thomas J. Stecz

		 	Thomas J. Stecz	 		 		 	Thomas J. Stecz
		 	Treasurer	 		 		 	Treasurer
			
	JEFFERSON BLANKING INC.	 		 	SHILOH AUTOMOTIVE, INC.
					
	By:	 	 /s/ Thomas M. Dugan
	 		 	By:	 	 /s/ Thomas J. Stecz

		 	Thomas M. Dugan	 		 		 	Thomas J. Stecz
		 	Assistant Secretary	 		 		 	Treasurer
					
	By:	 	 /s/ Thomas J. Stecz
	 		 		 	
		 	Thomas J. Stecz	 		 		 	
		 	Treasurer	 		 		 	

  

 Signature Page 1 of 2 to 
 Guarantor Acknowledgment and Agreement 

									
	 SHILOH INDUSTRIES, INC. DICKSON MANUFACTURING DIVISION
	 		 	LIVERPOOL COIL PROCESSING, INCORPORATED
					
	By:	 	 /s/ Thomas J. Stecz
	 		 	By:	 	 /s/ Thomas J. Stecz

		 	Thomas J. Stecz	 		 		 	Thomas J. Stecz
		 	Treasurer	 		 		 	Treasurer
			
	MEDINA BLANKING, INC.	 		 	THE SECTIONAL DIE COMPANY
					
	By:	 	 /s/ Thomas J. Stecz
	 		 	By:	 	 /s/ Thomas J. Stecz

		 	Thomas J. Stecz	 		 		 	Thomas J. Stecz
		 	Treasurer	 		 		 	Treasurer
				
	SECTIONAL STAMPING, INC.	 		 		 	
					
	By:	 	 /s/ Thomas J. Stecz
	 		 		 	
		 	Thomas J. Stecz	 		 		 	
		 	Treasurer	 		 		 	

  

 Signature Page 2 of 2 to 
 Guarantor Acknowledgment and Agreement 

 SCHEDULE 1 
  

										
	 LENDERS
	  	COMMITMENT
PERCENTAGE	 	 	REVOLVING
CREDIT
COMMITMENT
AMOUNT	  	MAXIMUM
AMOUNT
	 National City Bank
	  	29.1666666667	% 	 	$	27,708,333.34	  	$	27,708,333.34
	 The PrivateBank and Trust Company
	  	29.1666666667	% 	 	$	27,708,333.33	  	$	27,708,333.33
	 FirstMerit Bank, N.A.
	  	16.6666666666	% 	 	$	15,833,333.33	  	$	15,833,333.33
	 KeyBank National Association
	  	12.5000000000	% 	 	$	11,875,000.00	  	$	11,875,000.00
	 RBS Citizens, National Association
	  	12.5000000000	% 	 	$	11,875,000.00	  	$	11,875,000.00
				
	 Total Commitment Amount
	  	100.0000000000	% 	 	$	95,000,000	  	$	95,000,000
		  			 	 	 	  		

  

 S-1 

 EXHIBIT G 
 FORM OF 
 BORROWING FORMULA CERTIFICATE 
 See attached.NOL Preservation Lock-Up Agreement

 Exhibit 4.8 
 NOL PRESERVATION LOCK-UP AGREEMENT 
 This NOL PRESERVATION LOCK-UP AGREEMENT (this
“Agreement”) is made effective as of the Effective Date between Jazz Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the several investor signatories listed on Schedule A hereto (including
any successor or assign of any such investor, each an “Investor” and collectively, the “Investors”). 
 WHEREAS, the Company and each Investor deems it to be in the best interests of the Company to enter into this Agreement, to restrict transferability of such Investor’s Company capital stock in order to minimize the risk that the
Company will undergo an “ownership change” within the meaning of Section 382(g) of the Code that would subject use of its Tax Benefits to limitation under Section 382(a) of the Code. 
 NOW, THEREFORE, in consideration of the premises and the covenants and agreements hereinafter set forth, the parties hereby agree as follows: 

Section I 
 Definitions

 1.1 As used in this Agreement: 
 “Acquire” or “Acquisition” means the acquisition of record, legal, beneficial or any other ownership of Company Securities by any means, including, without limitation, (a) a purchase of Company
Securities from the owner thereof, whether effected through a private sale, an open market transaction, or otherwise, (b) the exercise of any rights under any option, warrant, convertible security, pledge or other security interest or similar
right to acquire Company Securities, or (c) the entering into of any swap, hedge or other arrangement that results in the acquisition of any of the economic consequences of ownership of Company Securities, but shall not in the case of clauses
(a) – (c) include any acquisition unless, as a result, the acquirer would be considered an owner of such Company Securities for United States federal income tax purposes. 
 “Business Day” means a day, other than a Saturday or Sunday, on which banks in New York City are open for the general transaction of
business. 
 “Code” means the Internal Revenue Code of 1986, as amended. 
 “Company Securities” means (a) shares of Common Stock of the Company, (b) shares of Preferred Stock of the Company of any
class or series, (c) any other interests in the Company not already described in clauses (a) or (b) that constitute “stock” of the Company pursuant to Treasury Regulation Section 1.382-2T(f)(18), and (d) warrants,
options or other rights to purchase stock of the Company (including interests described in Treasury Regulations Section 1.382-2T(h)(4)(v)). 
  

 1 

 “Effective Date” means the date upon which the last signature of each of the Investors
listed on Schedule A hereto has been delivered to the Company. 
 “Entity” means an entity within the meaning of
Treasury Regulation Section 1.382-3(a)(1). 
 “Fundamental Transaction” means (i) any consolidation or merger of
the Company with or into any other corporation or other entity or person, or any other corporate reorganization, in which the stockholders of the Company immediately prior to such consolidation, merger or reorganization own less than 50% of the
voting power of the surviving entity immediately after such consolidation, merger or reorganization, or (ii) the sale, transfer or other disposition of all or substantially all of the Company’s assets to another entity. 
 “Person” means an individual, corporation, estate, trust, association, limited liability company, partnership, joint venture or similar
organization, and also includes a syndicate or group as those terms are used for the purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended. 
 “Restriction Release Date” means the earlier of (i) June 24, 2011, (ii) immediately prior to the consummation of a Fundamental Transaction, (iii) such date as all Investors shall
agree in writing to terminate this Agreement or (iv) such date on which the Company in its sole judgment determines the restrictions contained in this Agreement are no longer needed and thereupon notifies the Investors in writing that the
restrictions set forth in this Agreement shall terminate. 
 “Restricted Activity” means (i) the Acquisition of
additional Company Securities by an Investor, (ii) the Transfer of any Company Securities currently owned by such Investor or entering into any agreements for such Transfer, (iii) distributing any Company Securities held by an Investor
that is an Entity to such Investor’s owners, or (iv) exercising any warrants or other rights to acquire Company stock described in clause (d) of the definition of Company Securities. 
 “Tax Benefits” means the net operating loss carryovers, capital loss carryovers, general business credit carryovers, alternative minimum
tax credit carryovers and foreign tax credit carryovers, as well as any “net unrealized built-in loss” within the meaning of Section 382 of the Code, of the Company, any direct or indirect subsidiary thereof, or any consolidated or
combined tax filing group of which the Company is a member. 
 “Transfer” means any direct or indirect, sale, transfer,
assignment, conveyance, pledge or other disposition of Company Securities in any manner whatsoever, whether voluntary or involuntary, by operation of law or otherwise, or any attempt to do any of the foregoing. A Transfer shall also include the
creation or grant of an option (including within the meaning of Treasury Regulation Section 1.382-2T(h)(4)(v)). 
 “Treasury
Regulation” means a Treasury Regulation promulgated under the Code. 
 1.2 Other defined terms shall have the meanings assigned to
them in the preamble to this Agreement or as defined elsewhere in this Agreement. 
  

 2 

 Section II 
 Restrictions on Stock held by the Investors 
 2.1 Approval Required for Restricted Activities.
From and after the Effective Date and prior to the Restriction Release Date, each Investor hereby agrees that it will not engage in any Restricted Activity without first obtaining the approval of Company in the manner set forth in this Section II.
Any purported Transfer made in violation of this Section 2.1 shall be null and void and shall not be effective to Transfer any record, legal, beneficial or any other ownership of the Company Securities in respect of such purported Transfer to
any transferee thereof. 
 2.2 Request for Approval. The restrictions contained in this Agreement are for the purpose of minimizing
the risk that any “ownership change” (as defined in Section 382(g) of the Code) with respect to the Company may limit the Company’s ability to utilize its Tax Benefits. In connection therewith, if an Investor proposes to
undertake a Restricted Activity, it shall, not less than ten (10) Business Days prior to the date of the proposed Restricted Activity, request in writing (a “Request”) that the Company review the proposed Restricted Activity
and authorize or not authorize the proposed Restricted Activity in accordance with this Section II. A Request shall be delivered in accordance with the Notice provisions of Section 4.11. Such Request shall be deemed to have been received by the
Company when actually received by the Company. A Request shall include (i) the name, address and telephone number of such requesting Investor, (ii) a description of the Restricted Activity that such Investor proposes to undertake,
(iii) the date on which the proposed Restricted Activity is expected to take place (or, if the proposed Restricted Activity consists of a transaction on a national securities exchange or any national securities quotation system, a statement to
that effect), (iv) the name of the counter party (or parties) to the proposed Restricted Activity (or, if the proposed Restricted Activity consists of a transaction on a national securities exchange or any national securities quotation system,
a statement to that effect) and (v) a request that the Company approve the proposed Restricted Activity pursuant to this Section II. 
 2.3 Approval by the Company. The Company may authorize a proposed Restricted Activity, if it determines, in its reasonable judgment, that the proposed Restricted Activity, when coupled with other
Restricted Activities, if any, proposed or expected to be proposed by other Company stockholders, would not be likely to result in an ownership change within the meaning of Section 382(g) of the Code that would be likely to limit the
Company’s ability to utilize its Tax Benefits. The Company may, in its sole discretion, impose any conditions that it deems reasonable and appropriate in connection with authorizing any such proposed Restricted Activity by an Investor. In
addition, the Company may, in its sole discretion, require such representations from such Investor or such opinions of counsel to be rendered by counsel selected or approved by the Company and at its expense, in each case as to such matters as the
Company may determine. The Company shall approve or disapprove a Request on or before the tenth (10th) Business Day following the Company’s receipt thereof. 
  

 3 

 Section III 
 Certain Remedies 
 3.1 Treatment of Unapproved Restricted Activity. The parties acknowledge
and agree that no employee or agent of the Company (including any transfer agent or registrar of the Company) shall record any purported Transfer that is made in violation of Section II, and the purported transferee of any such purported Transfer
shall not be recognized as a stockholder of the Company for any purpose whatsoever in respect of the Company Securities that are the subject thereof. The purported transferee of a Transfer that is made in violation of Section II shall not be
entitled with respect to such Company Securities to any rights of an owner thereof, including without limitation, any right to vote, or to receive dividends or distributions, in respect thereof, and the Company shall be entitled to so instruct its
transfer agent or registrar of the same. 
 3.2 Injunctions. Each Investor acknowledges that irreparable damage would occur in the
event that any of the provisions of this Agreement were not performed in accordance with its specified terms or were otherwise breached. The Company shall be entitled to an injunction or injunctions to prevent breaches of the provisions of this
Agreement and to enforce specifically the terms and provisions hereof in any court having jurisdiction, such remedy being in addition to any other remedy to which the Company may be entitled at law or equity. 
 Section IV 
 Miscellaneous

 4.1 Powers of the Board of Directors. Nothing contained in this Agreement shall limit the authority of the Board of Directors
of the Company to take such other action to the extent permitted by law as it deems necessary or advisable to preserve the Company’s Tax Benefits. The Board of Directors of the Company shall have the power to determine all matters necessary for
determining compliance with this Agreement. In the case of an ambiguity in the application of any of the provisions of this Agreement, including any definition used herein, the Board of Directors shall have the power to determine the application of
such provisions with respect to any situation based on its reasonable belief, understanding or knowledge of the circumstances. In the event that this Agreement requires an action by the Board of Directors but fails to provide specific guidance with
respect to such action, the Board of Directors shall have the power to determine the action to be taken so long as such action is not contrary to the provisions of this Agreement. All such actions, calculations, interpretations and determinations
that are done or made by the Board of Directors in good faith shall be final, conclusive and binding on the Company, and each Investor; provided, however, that the Board of Directors may delegate all or any portion of its duties and powers under
this Agreement to a committee of the Board of Directors as it deems advisable or necessary. 
 4.2 Legends. All certificates
reflecting Company Securities subject to this Agreement on or after the Effective Date shall, until the Restriction Release Date, bear a conspicuous legend in substantially the following form: 
 [THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION OF THIS SECURITY] [THESE SECURITIES] ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY
AND RESALE AND CERTAIN OTHER RESTRICTIONS, [INCLUDING EXERCISE OR 

  

 4 

 
CONVERSION RESTRICTIONS,] ALL AS SET FORTH IN A NOL PRESERVATION LOCK-UP AGREEMENT BETWEEN JAZZ PHARMACEUTICALS, INC. AND THE ORIGINAL HOLDER OF [THIS
SECURITY][THESE SECURITIES], A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICES OF JAZZ PHARMACEUTICALS, INC. 
 In order to give
effect to the foregoing, each Investor hereby agrees, immediately following the Effective Date, to surrender to the Company or to the Company’s transfer agent any Company Securities or certificates representing Company Securities held by such
Investor (endorsed or with stock powers attached, signatures guaranteed if so required by the Company’s transfer agent in the ordinary course of business, and otherwise in form necessary to effect reissuance) for the purpose of effecting the
reissuance of such Company Securities and certificates representing Company Securities containing the above legend. 
 The Company shall have
the power to make appropriate notations upon its stock transfer records and to instruct any transfer agent, registrar, securities intermediary or depository with respect to the requirements of this Agreement for any uncertificated Company Securities
or Company Securities held in an indirect holding system. 
 4.3 Entire Agreement. This Agreement constitutes and contains the entire
agreement and understanding of the Parties with respect to the subject matter hereof and supersedes any and all prior negotiations, correspondence, agreements, understandings, duties or obligations between the Parties with respect to the subject
matter hereof. 
 4.4 Amendments; Waivers. No provision of this Agreement may be waived or amended except in a written instrument
signed by each of the Company and each Investor. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a
waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. 
 4.5 Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability of the
remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall
incorporate such substitute provision in this Agreement. 
 4.6 Governing Law. All questions concerning the construction, validity,
enforcement and interpretation of this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflicts of law thereof. 
 4.7 Counterparts. This Agreement may be executed and delivered in one or more counterparts, and by the different parties hereto in separate
counterparts, each of which, when executed and delivered, shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. In the event that any signature is delivered by facsimile 

  

 5 

 
transmission, or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof. 
 4.8 Representations of the Parties. Each party hereto represents and warrants that the execution, delivery and performance by such party of the transactions contemplated by this Agreement have been duly
authorized by all necessary corporate or, if such party is not a corporation, such partnership, limited liability company or other applicable like action, on the part of such party. This Agreement has been duly executed by such party, and when
delivered by such party in accordance with the terms hereof, will constitute the valid and legally binding obligation of such party, enforceable against it in accordance with its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application. 
 4.9 Independent Nature of Investor Obligations. The obligations of each Investor under this Agreement are several and not joint with the
obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under this Agreement. Notwithstanding the foregoing, this Agreement shall not take effect unless and
until all parties named on Schedule A have executed, delivered and released their signature page(s) hereto to the Company. 
 4.10
Captions. Titles or captions of paragraphs contained in this Agreement are inserted only as a matter of convenience and for reference, and in no way define, limit, extend, or describe the scope of this Agreement or the intent of any provision
hereof. 
 4.11 Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder
shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via facsimile (provided the sender receives a machine-generated confirmation of successful
transmission) at the facsimile number specified in this Section 4.11 prior to 5:00 p.m., Pacific Time, on a Business Day, except in the event that the recipient is located outside the United States, in which case notice shall be deemed given
and effective on the next Business Day after the date of transmission, (b) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section on a
day that is not a Business Day or later than 5:00 p.m., Pacific Time, on any Business Day, (c) the Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service with next day delivery specified, or
in the event the recipient is located outside the United States, five (5) Business Day following the date of mailing, if sent by internationally recognized overnight courier service with next day delivery specified, or (d) upon actual
receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as follows: 
 If to the Company: 
 Jazz Pharmaceuticals, Inc. 
 3180 Porter Drive 
 Palo Alto, California
94304 
 Attention: General Counsel 
 Fax: (650) 496-3781 
  

 6 

 With a copy to (which shall not constitute notice): 
 Cooley Godward Kronish LLP 
 Five Palo Alto
Square 
 3000 El Camino Real 
 Palo Alto, California 94306-2155 
 Attention: Suzanne Sawochka Hooper, Esq. 
 Fax: (650) 849-7400 
 If to an
Investor: At the address set forth on its respective signature page attached hereto, or such other address as such Investor may designate by ten (10) days advance written notice to the other parties hereto. 
 [Signature Pages Follow] 
  

 7 

 IN WITNESS WHEREOF, the parties hereto have executed this NOL Preservation Lock-Up Agreement
effective as of the Effective Date. 
  

			
	JAZZ PHARMACEUTICALS, INC.,
	a Delaware corporation
		
	By:	 	 /s/    Bruce C. Cozadd

		 	Bruce C. Cozadd
		 	Chief Executive Officer
		
	Date:	 	 July 7, 2009

 IN WITNESS WHEREOF, the parties hereto have executed this NOL Preservation Lock-Up Agreement
effective as of the Effective Date. 
 INVESTORS: 
  

									
	 Longitude Venture Partners, L.P.
 a
Delaware Limited Partnership
	 		 	ADDRESS:
				
	 By:
 Its:
	 	 Longitude Capital Partners, LLC
 General
Partner
	 		 	 800 El Camino Real, Suite 220
 Menlo Park, CA
94025

					
	By:	 	 /s/    Patrick Enright
	 	(signature)	 		 	Fax: 650-854-5705
	Name:	 	 Patrick Enright
	 	(printed name)	 		 	
	Title:	 	Managing Member	 		 		 	
	  
 Date Signed and Delivered to the Company:
  
 July 6, 2009
	 		 	
			
	 Longitude Capital Associates, L.P.
 a
Delaware Limited Partnership
	 		 	ADDRESS:
				
	 By:
 Its:
	 	 Longitude Capital Partners, LLC
 General
Partner
	 		 	 800 El Camino Real, Suite 220
 Menlo Park, CA 94025

  
 Fax: 650-854-5705

	By:	 	 /s/    Patrick Enright
	 	(signature)	 		 	
	Name:	 	 Patrick Enright
	 	(printed name)	 		 	
	Title:	 	Managing Member	 		 	
	  
 Date Signed and Delivered to the Company:
  
 July 6, 2009
	 		 	

 IN WITNESS WHEREOF, the parties hereto have executed this NOL Preservation Lock-Up Agreement
effective as of the Effective Date. 
 INVESTORS: 
  

									
	KKR JP LLC	 		 	ADDRESS:
				
		 		 		 	9 W. 57th
Street, 42nd Floor
	Signature:	 	 /s/    Michael Michelson
	 		 	 New York, NY 10019
  

	Print Name:	 	 Michael Michelson
	 		 	Fax:	 	  

	Title:	 	 Member
	 		 		 	
				
	Date Signed and Delivered to the Company:	 		 		 	
				
	 July 6, 2009
	 		 		 	
			
	KKR JP III LLC	 		 	ADDRESS:
				
	Signature:	 	 /s/    Michael Michelson 
	 		 	 9 W. 57th Street, 42nd Floor
 New York, NY 10019
  

	Print Name:	 	 Michael Michelson
	 		 	Fax:	 	  

	Title:	 	 Member
	 		 		 	
				
	Date Signed and Delivered to the Company:	 		 		 	
				
	 July 6, 2009
	 		 		 	

 IN WITNESS WHEREOF, the parties hereto have executed this NOL Preservation Lock-Up Agreement
effective as of the Effective Date. 
 INVESTORS: 
  

							
	PROSPECT VENTURE PARTNERS II, L.P.	 		 	ADDRESS:
				
	By:	 	 Prospect Management Co. II, LLC,
 its General Partner

	 		 	 435 Tasso Street, Suite 200
 Palo Alto, CA
94301

							
				
	Signature:	 	 /s/    Dave Markland
	 		 	     Fax: 650-324-8838
				
	Print Name:	 	 Dave Markland
	 		 	
				
	Title:	 	 Attorney-in-Fact
	 		 	
			
	Date Signed and Delivered to the Company:	 		 	
			
	 July 6, 2009
	 		 	
			
	PROSPECT ASSOCIATES II, L.P.	 		 	     ADDRESS:

							
				
	By:	 	 Prospect Management Co. II, LLC,
 its General Partner

	 		 	              435 Tasso Street, Suite 200
              Palo Alto, CA 94301

							
				
	Signature:	 	 /s/    Dave Markland
	 		 	 Fax: 650-324-8838
				
	Print Name:	 	 Dave Markland
	 		 	
				
	Title:	 	 Attorney-in-Fact
	 		 	
			
	Date Signed and Delivered to the Company:	 		 	
			
	 July 6, 2009
	 		 	

  

 IN WITNESS WHEREOF, the parties hereto have executed this NOL Preservation Lock-Up Agreement
effective as of the Effective Date. 
 INVESTORS: 
  

							
	 VERSANT VENTURE CAPITAL II, L.P.
	  		  	ADDRESS:
				
	By:	  	 Versant Ventures II, L.L.C.,
 its General
Partner
	  		  	 3000 Sand Hill Road
 Building 4, Suite 210

Menlo Park, CA 94025

				
	Signature:	  	 /s/    Samuel D. Colella
	  		  	Fax: 650-854-9513
				
	Print Name:	  	 Samuel D. Colella
	  		  	
				
	Title:	  	 Managing Director
	  		  	
			
	Date Signed and Delivered to the Company:	  		  	
			
	 July 6, 2009
	  		  	
			
	 VERSANT SIDE FUND II, L.P.
	  		  	ADDRESS:
				
	By:	  	 Versant Ventures II, L.L.C.,
 its General
Partner
	  		  	 3000 Sand Hill Road
 Building 4, Suite 210

Menlo Park, CA 94025

				
	Signature:	  	 /s/    Samuel D. Colella
	  		  	Fax: 650-854-9513
				
	Print Name:	  	 Samuel D. Colella
	  		  	
				
	Title:	  	 Managing Director
	  		  	
			
	Date Signed and Delivered to the Company:	  		  	
			
	 July 6, 2009
	  		  	
			
	 VERSANT AFFILIATES FUND II-A, L.P.
	  		  	ADDRESS:
				
	By:	  	 Versant Ventures II, L.L.C.,
 its General
Partner
	  		  	 3000 Sand Hill Road
 Building 4, Suite 210

Menlo Park, CA 94025

				
	Signature:	  	 /s/    Samuel D. Colella
	  		  	Fax: 650-854-9513
				
	Print Name:	  	 Samuel D. Colella
	  		  	
				
	Title:	  	 Managing Director
	  		  	
			
	Date Signed and Delivered to the Company:	  		  	
			
	 July 6, 2009
	  		  	

 IN WITNESS WHEREOF, the parties hereto have executed this NOL Preservation Lock-Up Agreement
effective as of the Effective Date. 
 INVESTORS: 
  

									
	THOMA CRESSEY FUND VII, L.P.	 		 	ADDRESS:
				
	By:	 	TC Partners VII, L.P.	 		 	Sears Tower, 92nd
Floor
	Its:	 	General Partner	 		 	233 South Wacker Drive
		 		 		 	Chicago, IL 60606
	By:	 	Thoma Cressey Bravo Inc.	 		 	
	Its:	 	General Partner	 		 	Fax:	 	  

					
	Signature:	 	 /s/    Bryan C. Cressey
	 		 		 	
	Print Name:	 	 Bryan C. Cressey
	 		 		 	
	Title:	 	  
	 		 		 	
				
	Date Signed and Delivered to the Company:	 		 		 	
				
	July 6, 2009	 		 		 	
			
	THOMA CRESSEY FRIENDS FUND VII, L.P.	 		 	ADDRESS:
				
	By:	 	TC Partners VII, L.P.	 		 	Sears Tower, 92nd
Floor
	Its:	 	General Partner	 		 	233 South Wacker Drive
		 		 		 	Chicago, IL 60606
	By:	 	Thoma Cressey Bravo Inc.	 		 	
	Its:	 	General Partner	 		 	Fax:	 	  

					
	Signature:	 	 /s/    Bryan C. Cressey
	 		 		 	
	Print Name:	 	 Bryan C. Cressey
	 		 		 	
	Title:	 	  
	 		 		 	
				
	Date Signed and Delivered to the Company:	 		 		 	
				
	 July 6, 2009
	 		 		 	

 IN WITNESS WHEREOF, the parties hereto have executed this NOL Preservation Lock-Up Agreement
effective as of the Effective Date. 
 INVESTOR: 
  

							
	JAZZ INVESTORS, L.L.C.	 		 	ADDRESS:
				
	By:	 	 Beecken Petty & Company, L.L.C.,
 its
Manager
	 		 	 c/o Beecken Petty & Company Healthcare
 Equity Partners
 131 South Dearborn St., Suite 2800
 Chicago, IL 60603

	Signature:	 	  
 /s/    Kenneth W.
O’Keefe
	 		 
				
	Print Name:	 	 Kenneth W. O’Keefe
	 		 	
				
	Title:	 	 Partner
	 		 	Fax: 312-435-0371
			
	 Date Signed and Delivered to the Company:
  
 July 6, 2009
	 		 	
	 		 	

 SCHEDULE A 
 INVESTORS 
 Longitude Venture Partners, L.P. 
 Longitude Capital Associates, L.P. 
 KKR JP LLC 
 KKR JP III LLC 
 Prospect Venture Partners II, L.P. 
 Prospect Associates II, L.P. 
 Versant Venture Capital II, L.P. 
 Versant Side Fund II, L.P. 
 Versant Affiliates Fund II-A, L.P. 

Thoma Cressey Fund VII, L.P. 
 Thoma Cressey Friends Fund VII, L.P.

 Jazz Investors, L.L.C.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]